A Pennsylvania federal judge on Wednesday said buyers of reagents used in blood tests had satisfied the requirements to certify a class in an action alleging that a Johnson & Johnson unit conspired with another company to fix prices on the reagents.
U.S. District Judge Jan E. DuBois certified a class of direct purchasers that claim in the multidistrict litigation that J&J's Ortho-Clinical Diagnostics Inc. colluded with Immucor Inc. to raise prices on traditional blood reagents, which, among other purposes, are often used by hospitals and blood donor centers to test blood before transfusions or donations.
Immucor, also a named defendant in the suit, reached a $22 million class settlement that Judge DuBois preliminarily approved in March. Though final approval of that deal is pending, only Ortho-Clinical submitted filings in response to the motion for class certification, the judge said.
The complete article can be accessed here.